Purple Biotech Insider Deal: Shai’s Discounted Options Could Drive or Dilute Value
Explore how Lankry Shai’s insider options could dilute shareholders yet fuel Purple Biotech’s AI‑driven tri‑specific antibody platform, and what this means for investors.
5 minutes to read